by Jesse Nicassio | Jan 20, 2026 | Peptides
Tesamorelin, marketed under the brand name Egrifta, is a prescription peptide therapy best known for its ability to reduce visceral fat—the deep abdominal fat linked to metabolic disease. Originally approved for people living with HIV, Tesamorelin has gained broader...